Spleen News and Research

RSS
Research reveals new standard treatment options for various forms of lymphoma

Research reveals new standard treatment options for various forms of lymphoma

Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

How HIV kills CD4 T cells

How HIV kills CD4 T cells

Scientists reveal long-standing mystery about HIV infection

Scientists reveal long-standing mystery about HIV infection

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

YM BioSciences expands CYT387 Phase I/II clinical trial for myelofibrosis in five sites

YM BioSciences expands CYT387 Phase I/II clinical trial for myelofibrosis in five sites

Spleen cells may do more harm than good at site of spinal cord injury

Spleen cells may do more harm than good at site of spinal cord injury

Research suggests targeting spleen may promote healing of spinal cord injury

Research suggests targeting spleen may promote healing of spinal cord injury

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Idera presents data on TLR 3 agonist as vaccine adjuvants at Immunological Meeting

Idera presents data on TLR 3 agonist as vaccine adjuvants at Immunological Meeting

Systemic amyloidosis patient to receive triple organ transplant

Systemic amyloidosis patient to receive triple organ transplant

BAFF protein can promote aggressive leukemia and lymphomas

BAFF protein can promote aggressive leukemia and lymphomas

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

New disease pathways involving more than one cell type lead to Type 1 Gaucher disease: Study

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

Stanford medical school doctor, author teaches 'The art of the physicial'

Stanford medical school doctor, author teaches 'The art of the physicial'

Immunomedics receives additional patent claims for antibody therapy

Immunomedics receives additional patent claims for antibody therapy

Mt. Sinai surgeons pioneer scar-free gallbladder removal

Mt. Sinai surgeons pioneer scar-free gallbladder removal

Study finds usage of advanced radiology in emergency department increases

Study finds usage of advanced radiology in emergency department increases

As doctors rely on technology, physical exams often neglected

As doctors rely on technology, physical exams often neglected

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.